Cargando…
Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia
BACKGROUND: Rapid diagnostic tests based on histidine-rich protein 2 (HRP2) detection are the primary tools used to detect Plasmodium falciparum malaria infections. Recent conflicting reports call into question whether α-HRP2 antibodies are present in human host circulation and if resulting immune c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038308/ https://www.ncbi.nlm.nih.gov/pubmed/29986725 http://dx.doi.org/10.1186/s12936-018-2400-8 |
_version_ | 1783338473934028800 |
---|---|
author | Markwalter, Christine F. Mudenda, Lwiindi Leelawong, Mindy Kimmel, Danielle W. Nourani, Armin Mbambara, Saidon Thuma, Philip E. Wright, David W. |
author_facet | Markwalter, Christine F. Mudenda, Lwiindi Leelawong, Mindy Kimmel, Danielle W. Nourani, Armin Mbambara, Saidon Thuma, Philip E. Wright, David W. |
author_sort | Markwalter, Christine F. |
collection | PubMed |
description | BACKGROUND: Rapid diagnostic tests based on histidine-rich protein 2 (HRP2) detection are the primary tools used to detect Plasmodium falciparum malaria infections. Recent conflicting reports call into question whether α-HRP2 antibodies are present in human host circulation and if resulting immune complexes could interfere with HRP2 detection on malaria RDTs. This study sought to determine the prevalence of immune-complexed HRP2 in a low-transmission region of Southern Zambia. METHODS: An ELISA was used to quantify HRP2 in patient sample DBS extracts before and after heat-based immune complex dissociation. A pull-down assay reliant on proteins A, G, and L was developed and applied for IgG and IgM capture and subsequent immunoprecipitation of any HRP2 present in immune complexed form. A total of 104 patient samples were evaluated using both methods. RESULTS: Immune-complexed HRP2 was detectable in 17% (18/104) of all samples evaluated and 70% (16/23) of HRP2-positive samples. A majority of the patients with samples containing immune-complexed HRP2 had P. falciparum infections (11/18) and were also positive for free HRP2 (16/18). For 72% (13/18) of patients with immune-complexed HRP2, less than 10% of the total HRP2 present was in immune-complexed form. For the remaining samples, a large proportion (≥ 20%) of total HRP2 was complexed with α-HRP2 antibodies. CONCLUSIONS: Endogenous α-HRP2 antibodies form immune complexes with HRP2 in the symptomatic patient population of a low-transmission area in rural Southern Zambia. For the majority of patients, the percentage of HRP2 in immune complexes is low and does not affect HRP2-based malaria diagnosis. However, for some patients, a significant portion of the total HRP2 was in immune-complexed form. Future studies investigating the prevalence and proportion of immune-complexed HRP2 in asymptomatic individuals with low HRP2 levels will be required to assess whether α-HRP2 antibodies affect HRP2 detection for this portion of the transmission reservoir. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-018-2400-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6038308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60383082018-07-12 Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia Markwalter, Christine F. Mudenda, Lwiindi Leelawong, Mindy Kimmel, Danielle W. Nourani, Armin Mbambara, Saidon Thuma, Philip E. Wright, David W. Malar J Research BACKGROUND: Rapid diagnostic tests based on histidine-rich protein 2 (HRP2) detection are the primary tools used to detect Plasmodium falciparum malaria infections. Recent conflicting reports call into question whether α-HRP2 antibodies are present in human host circulation and if resulting immune complexes could interfere with HRP2 detection on malaria RDTs. This study sought to determine the prevalence of immune-complexed HRP2 in a low-transmission region of Southern Zambia. METHODS: An ELISA was used to quantify HRP2 in patient sample DBS extracts before and after heat-based immune complex dissociation. A pull-down assay reliant on proteins A, G, and L was developed and applied for IgG and IgM capture and subsequent immunoprecipitation of any HRP2 present in immune complexed form. A total of 104 patient samples were evaluated using both methods. RESULTS: Immune-complexed HRP2 was detectable in 17% (18/104) of all samples evaluated and 70% (16/23) of HRP2-positive samples. A majority of the patients with samples containing immune-complexed HRP2 had P. falciparum infections (11/18) and were also positive for free HRP2 (16/18). For 72% (13/18) of patients with immune-complexed HRP2, less than 10% of the total HRP2 present was in immune-complexed form. For the remaining samples, a large proportion (≥ 20%) of total HRP2 was complexed with α-HRP2 antibodies. CONCLUSIONS: Endogenous α-HRP2 antibodies form immune complexes with HRP2 in the symptomatic patient population of a low-transmission area in rural Southern Zambia. For the majority of patients, the percentage of HRP2 in immune complexes is low and does not affect HRP2-based malaria diagnosis. However, for some patients, a significant portion of the total HRP2 was in immune-complexed form. Future studies investigating the prevalence and proportion of immune-complexed HRP2 in asymptomatic individuals with low HRP2 levels will be required to assess whether α-HRP2 antibodies affect HRP2 detection for this portion of the transmission reservoir. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-018-2400-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-09 /pmc/articles/PMC6038308/ /pubmed/29986725 http://dx.doi.org/10.1186/s12936-018-2400-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Markwalter, Christine F. Mudenda, Lwiindi Leelawong, Mindy Kimmel, Danielle W. Nourani, Armin Mbambara, Saidon Thuma, Philip E. Wright, David W. Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia |
title | Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia |
title_full | Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia |
title_fullStr | Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia |
title_full_unstemmed | Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia |
title_short | Evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in Southern Zambia |
title_sort | evidence for histidine-rich protein 2 immune complex formation in symptomatic patients in southern zambia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038308/ https://www.ncbi.nlm.nih.gov/pubmed/29986725 http://dx.doi.org/10.1186/s12936-018-2400-8 |
work_keys_str_mv | AT markwalterchristinef evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia AT mudendalwiindi evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia AT leelawongmindy evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia AT kimmeldaniellew evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia AT nouraniarmin evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia AT mbambarasaidon evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia AT thumaphilipe evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia AT wrightdavidw evidenceforhistidinerichprotein2immunecomplexformationinsymptomaticpatientsinsouthernzambia |